Skip to main content

Table 2 Outcome of patients before and after propensity score matching

From: Remifentanil use in critically Ill patients requiring mechanical ventilation is associated with increased delirium-free days: a retrospective study

-

 

Before Matching (n = 95)

After Matching (n = 62)

Overall (n = 95)

Remifentanil Group (n = 32)

Non remifentanil Group (n = 63)

P-value

Remifentanil Group (n = 31)

Non remifentanil Group (n = 31)

P-value

Ventilator free days at 14 days, median [IQR]

1 [0–2]

8 [4–11]

9 [7–12]

0.035

8 [4–11]

9 [4–11]

0.392

Delirium, n (%)

34 (36.2)

11 (34.4)

23 (37.1)

0.825

11 (34.4)

15 (48.4)

0.44

Delirium Free Days at 14 days, median [IQR]

6 [3–9]

8 [4.5–10.7]

6 [3–11]

0.011

8 [5–11]

5 [3–9]

< .001

  1. Abbreviations: APACHEII Acute Physiology and Chronic Health Evaluation II, CPOT Critical-Care Pain Observation Tool, IQR Interquartile range, RASS Richmond Agitation-Sedation Scale, SMD Standardized Mean Difference, SOFA sequential organ failure assessment